New Brunswick, New Jersey
September 14, 2007
Senesco Technologies, Inc.
(AMEX:SNT) announced today that Dr. John E. Thompson, the
Company's Executive Vice President and CSO, will be an invited
speaker at the University of California, Davis's Plant Sciences
Symposium.
This symposium's topic is
Translational Seed Biology: From Model Systems to Crop
Improvement.
Dr. Thompson's presentation
will be titled "Enhancement of seed yield and size by eIF-5A
expression." His talk will take place at 11:00 a.m. PT on
September 18, 2007.
This Plant Sciences Symposium is the inaugural symposium of what
is planned to be an annual series. Speakers are drawn from
academia, research organizations, private industry and
stakeholder groups. The meeting will run from September 17-20 at
the campus of the University of California, Davis.
Senesco Technologies, Inc. is a U.S. biotechnology company,
headquartered in New Brunswick, NJ. Senesco has initiated
preclinical research to trigger or delay cell death in mammals
(apoptosis) to determine if the technology is applicable in
human medicine.
Accelerating apoptosis may have applications to development of
cancer treatments. Delaying apoptosis may have applications to
certain inflammatory and ischemic diseases. Senesco takes its
name from the scientific term for the aging of plant cells:
senescence. Delaying cell breakdown in plants extends freshness
after harvesting, while increasing crop yields, plant size and
resistance to environmental stress. The Company believes that
its technology can be used to develop superior strains of crops
without any modification other than delaying natural plant
senescence. Senesco has partnered with leading-edge companies
engaged in agricultural biotechnology and earns research and
development fees for applying its gene-regulating platform
technology to enhance its partners' products. |
|
